Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Post-irradiation glucan administration enhances the radioprotective effects of WR-2721. Scientific report

Technical Report ·
OSTI ID:5842482

Based on murine survival studies, endogeneous hemopoietic spleen colony formation (E-CFU), and recovery of bone marrow and splenic granulocyte-macrophage colony-forming cells(GM-CFC), it was demonstrated that the postirradiation administration of glucan, an immunomodulator and hemopoietic stimulant, enhances the radioprotective effects of WR-2721. These effects appeared to depend on the sequential cell protection mediated by WR-2721 and hemopoietic repopulation mediated by glucan.

Research Organization:
Armed Forces Radiobiology Research Inst., Bethesda, MD (USA)
OSTI ID:
5842482
Report Number(s):
AD-A-207915/0/XAB; AFRRI-SR-89-10
Country of Publication:
United States
Language:
English